ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
港股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
生物醫藥B類股
500.166
+17.011
3.52%
手動刷新
漲家數:
19
跌家數:
10
平家數:
4
市盈率:
- -
高:
500.431
開:
483.278
低:
478.821
收:
483.155
成交量:
3,888.40萬
成交額:
14.06億
市值:
3,176.01億
流通市值:
2,827.18億
資料載入中...
總覽
新聞
《業績》北海康成製藥(01228.HK)中期盈轉虧蝕3709萬人民幣
阿斯达克财经
·
08/31
大行評級丨高盛:上調諾誠健華目標價至22.71港元,未來12至18個月催化劑眾多
格隆汇
·
08/31
迪哲醫藥、劇星傳媒遞表港交所;星環科技通過港交所聆訊|港交所早參
每日经济新闻
·
08/31
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BK1574/news?page=18"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"生物醫藥B類股","latestPrice":500.16577,"timestamp":1789354455879,"preClose":483.15506,"halted":0,"volume":38883973,"delay":0,"changeRate":0.035208,"floatShares":0,"shares":0,"eps":0,"marketStatus":"交易中","change":17.010712,"latestTime":"09-14 10:54:16","open":483.2777,"high":500.43085,"low":478.82104,"amount":1406334584,"amplitude":0.044726,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"午間休市","tradingStatus":4,"beginTime":1789358400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789349400000,1789358400000],[1789362000000,1789372800000]],"pbRate":3.606253,"peRate":160.422718,"turnoverRate":0.00148,"increases":19,"decrements":10,"flats":3,"marketCap":317601049360,"floatMarketCap":282718240488},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":500.43085,"amplitude":0.044726,"preClose":483.15506,"low":478.82104,"pbRate":"3.606253","latestPrice":500.16577,"volume":38883973,"delay":0,"open":483.2777,"prevYearClose":556.26263,"prevWeekClose":483.155,"prevMonthClose":503.398,"prevQuarterClose":453.519,"fiveDayClose":516.325,"twentyDayClose":505.128,"sixtyDayClose":444.911,"secType":"PLATE","market":"HK","turnoverRate":0.00148,"peRate":160.422718,"marketCap":317601049360,"floatMarketCap":282718240488,"timestamp":1789354455879,"nameCN":"生物醫藥B類股"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":19,"down":10,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:18,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2663024324","title":"《業績》北海康成製藥(01228.HK)中期盈轉虧蝕3709萬人民幣","url":"https://stock-news.laohu8.com/highlight/detail?id=2663024324","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663024324?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 12:32","pubTimestamp":1788150720,"startTime":"0","endTime":"0","summary":"北海康成制药(01228.HK) 公布2026年6月底止六个月中期业绩,收入2,794万人民币(下同),按年升25.6%。盈转亏蚀3,709万,上年同期纯利5,924万;每股亏损7分。不派息。(ad/)(港股报价延迟最少十五分钟。)过往派息公布日期派息事项派息内容2026/03/30末期业绩无派息2025/08/31中期业绩无派息2025/03/31末期业绩无派息2024/08/30中期业绩无派息AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220106153104382_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220106153104382_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542088/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1542088/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","MCNHmain","01477","MUCmain","CYB","UCmain","BK1161","CNHmain","BK1574","01228"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663502955","title":"大行評級丨高盛:上調諾誠健華目標價至22.71港元,未來12至18個月催化劑眾多","url":"https://stock-news.laohu8.com/highlight/detail?id=2663502955","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663502955?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 10:47","pubTimestamp":1788144425,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["09969","BK1574","688428","BK1161","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663902673","title":"迪哲醫藥、劇星傳媒遞表港交所;星環科技通過港交所聆訊|港交所早參","url":"https://stock-news.laohu8.com/highlight/detail?id=2663902673","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663902673?lang=zh_tw&edition=fundamental","pubTime":"2026-08-31 10:26","pubTimestamp":1788143206,"startTime":"0","endTime":"0","summary":"|2026年8月31日星期一|NO.1迪哲医药、剧星传媒递表港交所据港交所8月27日披露,迪哲(江苏)医药股份有限公司(以下简称迪哲医药,SH688192)、上海剧星传媒股份有限公司(以下简称剧星传媒)已向港交所主板递交上市申请。迪哲医药是一家处于商业化阶段的生物制药公司,公司的核心治疗领域是肿瘤及血液系统疾病。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608313859847470.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608313859847470.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1128","BK1574","159938","BK1515","IPOS","91222","01981","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":18,"totalSize":343,"code":"91000000","status":"200"}]}}